Standardized orthotopic xenografts in zebrafish reveal glioma cell-line-specific characteristics and tumor cell heterogeneity

Keyphrases

• Zebrafish 100%
• Glioma Cell Lines 100%
• Glioblastoma 100%
• Orthotopic Xenograft 100%
• Tumor Cell Heterogeneity 100%
• Tumor 66%
• Tumor Cells 66%
• Tumor Growth 66%
• Adherent Cells 66%
• Vimentin 66%
• Glial Fibrillary Acidic Protein 66%
• Standardized Approach 66%
• Neurosphere Cells 66%
• Cell number 33%
• Bortezomib 33%
• Cell-to-cell 33%
• Stem Cells 33%
• Tumor Formation 33%
• Tumor Volume 33%
• Brain Tumor 33%
• Drug Treatment 33%
• Dose-response 33%
• Tumor Burden 33%
• Mouse Neural Stem Cells 33%
• Differentiated Cells 33%
• Lethality 33%
• Midbrain 33%
• Temozolomide 33%
• Effective Compounds 33%
• Stem Cell Markers 33%
• Data Comparison 33%
• Cell Spreading 33%
• Sex-determining Region Y-box 2 (SOX2) 33%
• Neurospheres 33%
• Brain Cancer 33%
• Brain Tumor Progression 33%
• Optimal number 33%
• Drug Screening 33%
• Zebrafish Model 33%
• Marker-and-cell 33%
• Embryonic Zebrafish 33%
• Standardized Model 33%
• Reproducible Analysis 33%
• Robustness Analysis 33%
• Xenotransplant 33%
• Glioblastoma Tumor 33%
• Glioblastoma Cell Line 33%
• Survival Assay 33%

Neuroscience

• Cell Line 100%
• Neurosphere 100%
• Glioma 100%
• In Vivo 66%
• Vimentin 66%
• Glial Fibrillary Acidic Protein 66%
• Intracranial Tumor 66%
• Midbrain 33%
• Bortezomib 33%
• Neural Stem Cell 33%
• Stem Cell 33%
• Carcinogenesis 33%
• Brain Cancer 33%
• Temozolomide 33%
• Drug Therapy 33%